Találati lista | Tudóstér

001-es BibID:	BIBFORM103008
035-os BibID:	(cikkazonosító)873899 (WOS)000836963900001 (Scopus)85135499583
Első szerző:	Csató Gábor
Cím:	Predictors of restenosis following percutaneous coronary stent implantation : the role of trimetazidine therapy / Csató Gábor, Erdei Nóra, Ványai Beatrix, Balla Tímea, Czuriga Dániel, Csanádi Zoltán, Koszegi Zsolt, Édes István, Szabó Gábor Tamás
Dátum:	2022
ISSN:	2297-055X
Megjegyzések:	Aims: In-stent restenosis (ISR) is an unresolved problem following percutaneous coronary intervention (PCI), having a negative impact on clinical outcome. The main goal of this study was to find new independent predictors that may influence the development of ISR. Methods and results: In this retrospective analysis, 653 PCI patients were involved. All patients had coronary stent implantation and a follow-up coronary angiography. Based on the presence of ISR at follow-up, patients were divided into two groups: 221 in the ISR and 432 in the control group. When evaluating the medical therapy of patients, significantly more patients were on trimetazidine (TMZ) in the control compared to the ISR group (p = 0.039). TMZ was found to be an independent predictor of a lower degree of ISR development (p = 0.007). TMZ treatment was especially e??ective in baremetal stent (BMS)-implanted chronic coronary syndrome (CCS) patients with narrow coronary arteries. The inflammation marker neutrophil to lymphocyte ratio (NLR) was significantly elevated at baseline in the ISR group compared to controls. The reduction of post-PCINLR was associated with improved e cacy of TMZ to prevent ISR development. Drug eluting stent implantation (p<0.001) and increased stent diameter (p<0.001) were themost important independent predictors of a lower degree of ISR development, while the use of longer stents (p = 0.005) was a major independent predictor of an increased ISR risk. Conclusion: TMZ reduces the occurrence of ISR following PCI, with special e??ectiveness in BMS-implanted patients having CCS and narrow coronary arteries. TMZ treatmentmay help to lower ISR formation in countries with high BMS utilization rates.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk in-stent restenosis trimetazidine (TMZ) percutaneous coronary intervention (PCI) anti-inflammatory effect stent implantation
Megjelenés:	Frontiers in Cardiovascular Medicine. - 9 (2022), p. 1-9. -
További szerzők:	Erdei Nóra (1979-) (orvos) Ványai Beatrix Balla Tímea Czuriga Dániel (1982-) (kardiológus) Csanádi Zoltán (1960-) (kardiológus) Kőszegi Zsolt (1962-) (kardiológus, belgyógyász) Édes István (1952-) (kardiológus) Szabó Gábor Tamás (1982-) (kardiológus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: